Valuation: NeurAxis, Inc.

Market Cap 96.69M 86.21M 79.7M 72.55M 137M 9.18B 139M 960M 377M 4.79B 363M 355M 15.26B P/E 2026 *
-7.06x
P/E 2027 * -28.5x
Enterprise Value 96.69M 86.21M 79.7M 72.55M 137M 9.18B 139M 960M 377M 4.79B 363M 355M 15.26B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 4.88x
Free-Float
74.64%
Yield 2026 *
-
Yield 2027 * -
1 day-0.52%
1 week+11.11%
Current month+4.48%
1 month+1.18%
3 months+14.07%
6 months+6.65%
Current year+69.60%
1 week 6
Extreme 6
7.84
1 month 6
Extreme 6
8.05
Current year 4.12
Extreme 4.125
9.33
1 year 2.21
Extreme 2.21
9.33
3 years 1.33
Extreme 1.33
9.33
5 years 1.33
Extreme 1.33
9.33
10 years 1.33
Extreme 1.33
9.33
Manager TitleAgeSince
Corporate Officer/Principal 72 2010-12-31
Chief Executive Officer - 2010-12-31
Chief Executive Officer 44 2011-12-31
Director TitleAgeSince
Director/Board Member 44 2011-12-31
Director/Board Member 72 2010-12-31
Chairman 51 -
Date Insider Type Main position Quantity % Market Cap. Importance
10/8/26 Buy

Chief Executive Officer

268 0.0021%
10/8/26 Buy

Chief Financial Officer

1,937 0.0154%
10/8/26 Buy

Compliance Officer

328 0.0026%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+11.11%+154.13%+136.20% 96.69M
+0.20%+5.31%-18.40%+9.76% 181B
-0.73%+7.09%-1.08%+30.33% 116B
+0.49%+6.25%-21.30%+9.06% 113B
+3.83%+5.50%-50.59%-5.64% 79.83B
-0.14%+5.27%+5.00%+79.86% 65.06B
+2.79%+2.37%+15.85%+65.97% 54.35B
-1.04%+4.35%+1.40%-26.08% 52.23B
+2.41%+8.18%-11.81%+31.75% 44.15B
-1.90%+2.29%+29.19%+2.28% 32.47B
Average +0.54%+5.87%+10.24%+33.35% 73.87B
Weighted average by Cap. +0.60%+5.59%-11.11%+20.00%

Financials

2026 *2027 *
Net sales 8.3M 7.4M 6.84M 6.23M 11.72M 788M 11.91M 82.37M 32.32M 411M 31.15M 30.48M 1.31B 19.8M 17.65M 16.32M 14.86M 27.97M 1.88B 28.42M 196M 77.11M 981M 74.3M 72.72M 3.12B
Net income -12.9M -11.5M -10.63M -9.68M -18.22M -1.22B -18.52M -128M -50.24M -639M -48.41M -47.38M -2.04B -3.5M -3.12M -2.88M -2.63M -4.94M -332M -5.02M -34.73M -13.63M -173M -13.13M -12.85M -552M
Net Debt - -
Projected Income Statement - Annual - NeurAxis, Inc.
Logo NeurAxis, Inc.
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies for chronic and debilitating conditions in gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. Its IB-Stim, is a Percutaneous Electrical Nerve Field Stimulation (PENFS) technology intended to be used in patients eight years and older with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. Its second product, RED (Rectal Expulsion Device), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge to defecate at lower volumes of distension.
Employees
24
Date Price Change Volume
26-10-16 US$7.700 -0.52% 229,381
26-10-15 US$7.740 +18.53% 1,127,094
26-10-14 US$6.530 +0.46% 173,086
26-10-13 US$6.500 -3.27% 118,077
26-10-12 US$6.720 -3.03% 74,639
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - NeurAxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.700USD
Average target price
11.00USD
Spread / Average Target
+42.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - NeurAxis, Inc.
  1. Stock Market
  2. Stocks
  3. NRXS Stock